Health AI hits point-solution burnout as demand for real value grows
Add Axios as your preferred source to
see more of our stories on Google.
Illustration: Lindsey Bailey/Axios
As the health AI market matures, the pressure to deliver real value for all stakeholders is intensifying.
The big picture: Point solution fatigue is starting to include the growing cadre of health care AI offerings.
By the numbers: As of September 30, 45% of first fundings for new health tech startups embedded AI in their products, per a JPMorgan report.
What they're saying: "Adoption is contingent on knowing your user, knowing the workflow and solving for them," Avo CEO Yair Saperstein says, speaking at an event ahead of Axios' AI+ Summit in San Francisco on Thursday.
- "The only way really, to solve for [point solution fatigue] is understanding the workflow and then being able to build for that," he says.
- Hospitals want a solution "that drives where the patients get the value of access, providers get the value of a predictable workflow [and] the CFO gets the operative margin," Qventus chief medical officer David Atashroo says.
Yes, but: Panelists are optimistic about finding areas that serve patients while appeasing those bearing the brunt of associated costs.
- Several highlight efforts at consumer-focused businesses like smart ring maker Oura, which is building out its payor partnerships.
- Meanwhile, pharma companies — which typically don't interact directly with patients beyond advertising to them — are increasing consumer engagement.
- "There's a great opportunity for the patient to have a stronger voice in the health system," says Sunil Verma, global head of oncology at AstraZeneca, which recently partnered with Salesforce to use its AI agents.
What's next: Personalized medicine will draw more interest, as new companies emerge, says Arm chief marketing officer Ami Badani.
- Digital twin technology that can create more complete stories of a patient's condition is one growing area, says Mark Palmer, health care CTO at Synopsys.
